Metabolic syndrome and target organ damage in untreated essential hypertensives

Journal of Hypertension
Cesare CuspidiA Zanchetti

Abstract

The prevalence and the relationship between metabolic syndrome, and target organ damage (TOD) in essential hypertensive patients has not been fully explored to date. To investigate the association between metabolic syndrome, as defined by the ATP III report, and cardiac and extracardiac TOD, as defined by the 2003 ESH-ESC guidelines for management of hypertension, in a large population of never-treated essential hypertensives. A total of 447 grade 1 and 2 hypertensive patients (mean age 46 +/- 12 years) who were attending a hypertension hospital outpatient clinic for the first time underwent the following procedures: (i) physical examination and repeated clinic blood pressure measurements; (ii) routine examinations; (iii) 24-h urine collection for microalbuminuria; (iv) 24-h ambulatory blood pressure monitoring; (v) echocardiography; and (vi) carotid ultrasonography. Metabolic syndrome was defined as involving at least three of the following alterations: increased waist circumference, increased triglycerides, decreased high-density lipoprotein cholesterol, increased blood pressure, or high fasting glucose. Left ventricular hypertrophy (LVH) was defined according to two different criteria: (i) 125 g/m in men and 110 g/m in women...Continue Reading

References

Nov 1, 1992·Journal of Internal Medicine·H ErikssonG Tibblin
Dec 1, 1992·Annals of Medicine·Y A KesäniemiA Rantala
Jun 1, 1992·Journal of the American College of Cardiology·A GanauJ H Laragh
Apr 1, 1988·Metabolism: Clinical and Experimental·S M HaffnerJ K Patterson
Mar 1, 1985·The Journal of Clinical Investigation·M ModanZ Fuchs
Dec 1, 1995·Journal of Hypertension·G ManciaA Zanchetti
Nov 26, 1998·American Journal of Epidemiology·M TrevisanA Menotti
Mar 19, 1999·Journal of Internal Medicine·A O RantalaY A Kesäniemi
Sep 9, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·J HultheB Fagerberg
Feb 15, 2001·Archives of Internal Medicine·UNKNOWN DECODE Study Group, the European Diabetes Epidemiology Group.
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Jan 16, 2002·JAMA : the Journal of the American Medical Association·Earl S FordWilliam H Dietz
Oct 3, 2002·Circulation·Hans L HillegeUNKNOWN Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group
Jun 5, 2003·Journal of Hypertension·UNKNOWN European Society of Hypertension-European Society of Cardiology Guidelines Committee
Oct 24, 2003·American Journal of Hypertension·Latha PalaniappanStephen P Fortmann

❮ Previous
Next ❯

Citations

Oct 12, 2007·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Robert H Mak
Mar 28, 2008·Current Diabetes Reports·Francesco FalloPaolo Mulatero
Apr 20, 2007·Current Hypertension Reports·Francesco FalloPaolo Mulatero
Mar 28, 2008·Current Hypertension Reports·Cesare CuspidiAlberto Zanchetti
Dec 15, 2006·Cardiovascular Research·Naveen SharmaWilliam C Stanley
Dec 3, 2010·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Gregory VyssoulisChristodoulos Stefanadis
Mar 29, 2008·Metabolic Syndrome and Related Disorders·Stanley S Franklin
Apr 18, 2008·Nutrition Journal·Hidekatsu YanaiNorio Tada
Nov 1, 2011·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Stijntje D RoesAlbert de Roos
Sep 9, 2006·The Tohoku Journal of Experimental Medicine·Zeynep TartanNese Cam
Dec 17, 2008·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Branislava IvanovićDragan Simić
Sep 3, 2014·Osong Public Health and Research Perspectives·Dhananjay YadavG B K S Prasad
Jun 16, 2012·Indian Journal of Endocrinology and Metabolism·Charles U Osuji, Emeka G Omejua
Jul 30, 2014·Metabolic Syndrome and Related Disorders·Ebenezer Adekunle AjayiOlatayo Adekunle Adeoti
Jul 13, 2006·Current Medical Research and Opinion·Jirí Widimský, Jana Sirotiaková
Sep 30, 2008·Blood Pressure·Cesare CuspidiGiuseppe Mancia
Jun 26, 2015·Journal of Human Hypertension·E RattoR Pontremoli
Apr 23, 2011·Medicina clínica·Alejandro de la SierraDiego González-Segura
Feb 13, 2009·Medicina clínica·José Luis LlisterriUNKNOWN en representación de los investigadores del estudio PREV-ICTUS
Jan 30, 2007·International Journal of Cardiology·Giuseppe MulèGiovanni Cerasola
May 25, 2005·Journal of Internal Medicine·G MulèG Cerasola
Jul 21, 2009·Journal of the Cardiometabolic Syndrome·Azra MahmudJohn Feely
Mar 9, 2006·The Journal of Clinical Hypertension·Giuseppe Mulè, Giovanni Cerasola
Sep 17, 2013·Experimental Physiology·Sara B FournierPaul D Chantler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.